175 related articles for article (PubMed ID: 11514038)
21. Interval estimation of binomial proportion in clinical trials with a two-stage design.
Tsai WY; Chi Y; Chen CM
Stat Med; 2008 Jan; 27(1):15-35. PubMed ID: 17566141
[TBL] [Abstract][Full Text] [Related]
22. Randomized phase II clinical trials.
Jung SH; Sargent DJ
J Biopharm Stat; 2014; 24(4):802-16. PubMed ID: 24697589
[TBL] [Abstract][Full Text] [Related]
23. Approaches to handling data when a phase II trial deviates from the pre-specified Simon's two-stage design.
Wu Y; Shih WJ
Stat Med; 2008 Dec; 27(29):6190-208. PubMed ID: 18800338
[TBL] [Abstract][Full Text] [Related]
24. Multistage designs for phase II clinical trials: statistical issues in cancer research.
Kramar A; Potvin D; Hill C
Br J Cancer; 1996 Oct; 74(8):1317-20. PubMed ID: 8883425
[TBL] [Abstract][Full Text] [Related]
25. [Research design for patient selection in clinical trials phase II].
Kramar A; Potvin D; Hill C
Rev Epidemiol Sante Publique; 1996 Aug; 44(4):364-71. PubMed ID: 8927779
[TBL] [Abstract][Full Text] [Related]
26. On the estimation of the binomial probability in multistage clinical trials.
Jung SH; Kim KM
Stat Med; 2004 Mar; 23(6):881-96. PubMed ID: 15027078
[TBL] [Abstract][Full Text] [Related]
27. Optimal two-stage designs for single-arm phase II oncology trials with two binary endpoints.
Kunz CU; Kieser M
Methods Inf Med; 2011; 50(4):372-7. PubMed ID: 21057719
[TBL] [Abstract][Full Text] [Related]
28. Proper inference from Simon's two-stage designs.
Koyama T; Chen H
Stat Med; 2008 Jul; 27(16):3145-54. PubMed ID: 17960777
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of two-stage designs of Phase 2 single-arm trials in glioblastoma: a systematic review.
Yoo W; Kim S; Garcia M; Mehta S; Sanai N
BMC Med Res Methodol; 2022 Dec; 22(1):327. PubMed ID: 36550391
[TBL] [Abstract][Full Text] [Related]
30. Randomized two-stage Phase II clinical trial designs based on Barnard's exact test.
Shan G; Ma C; Hutson AD; Wilding GE
J Biopharm Stat; 2013; 23(5):1081-90. PubMed ID: 23957517
[TBL] [Abstract][Full Text] [Related]
31. Adaptive designs for single-arm phase II trials in oncology.
Englert S; Kieser M
Pharm Stat; 2012; 11(3):241-9. PubMed ID: 22411839
[TBL] [Abstract][Full Text] [Related]
32. Reasonable two-stage adaptive designs for single-arm phase II clinical trials.
Kashiwabara K; Matsuyama Y
Pharm Stat; 2018 Nov; 17(6):770-780. PubMed ID: 30168250
[TBL] [Abstract][Full Text] [Related]
33. Point estimation and p-values in phase II adaptive two-stage designs with a binary endpoint.
Kunzmann K; Kieser M
Stat Med; 2017 Mar; 36(6):971-984. PubMed ID: 28028823
[TBL] [Abstract][Full Text] [Related]
34. Extended two-stage adaptive designs with three target responses for phase II clinical trials.
Kim S; Wong WK
Stat Methods Med Res; 2018 Dec; 27(12):3628-3642. PubMed ID: 28535716
[TBL] [Abstract][Full Text] [Related]
35. A Rescue Strategy for Handling Unevaluable Patients in Simon's Two Stage Design.
Belin L; Broët P; De Rycke Y
PLoS One; 2015; 10(9):e0137586. PubMed ID: 26368810
[TBL] [Abstract][Full Text] [Related]
36. Optimal designs for phase II clinical trials with heterogeneous patient populations.
Liu L; Cao S; Jung SH
J Biopharm Stat; 2023 Jan; 33(1):1-14. PubMed ID: 35793231
[TBL] [Abstract][Full Text] [Related]
37. An optimal three-stage design for phase II clinical trials.
Ensign LG; Gehan EA; Kamen DS; Thall PF
Stat Med; 1994 Sep; 13(17):1727-36. PubMed ID: 7997706
[TBL] [Abstract][Full Text] [Related]
38. Admissible two-stage designs for phase II cancer clinical trials that incorporate the expected sample size under the alternative hypothesis.
Mander AP; Wason JM; Sweeting MJ; Thompson SG
Pharm Stat; 2012; 11(2):91-6. PubMed ID: 22232071
[TBL] [Abstract][Full Text] [Related]
39. Optimal continuous-monitoring design of single-arm phase II trial based on the simulated annealing method.
Chen N; Lee JJ
Contemp Clin Trials; 2013 May; 35(1):170-8. PubMed ID: 23545075
[TBL] [Abstract][Full Text] [Related]
40. A randomized two-stage design for phase II clinical trials based on a Bayesian predictive approach.
Cellamare M; Sambucini V
Stat Med; 2015 Mar; 34(6):1059-78. PubMed ID: 25545805
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
